A Novel Anticoagulation Strategy for High‐Volume Plasma Exchange in Pediatric Patients With Acute Liver Failure
Pediatric Transplantation · 2025
DOI: 10.1111/petr.70213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Amanda M Walker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Critical Care, Nemours Children's Hospital, Delaware, Wilmington, Delaware, USA. Hauptthemen laut MEDLINE: Liver Failure, Acute, Plasma Exchange, Anticoagulants, Heparin. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Pediatric acute liver failure represents a significant health care concern with significant morbidity and mortality. High‐volume plasma exchange has been shown to serve as an effective blood purification technique that has allowed patients with ALF to survive to liver transplantation, or in some cases even spontaneous recovery. This study describes a novel anticoagulation protocol using a combination of citrate and heparin for high‐volume plasma exchange in pediatric acute liver failure patients and demonstrates the safety of high‐volume plasma exchange in pediatric acute liver failure patients.
Methods
This study retrospectively reviews a series of patients younger than 18 years of age with acute liver failure, analyzing the safety of high‐volume plasma exchange in a single‐center tertiary pediatric intensive care unit.
Results
Twelve encounters with 11 unique patients were included. Switching anticoagulation from citrate only to citrate plus heparin decreased the incidence of citrate lock from 80% to 25% (odds ratio 0.083), with no bleeding complications. No patients experienced life‐threatening adverse events. Non‐severe adverse events occurred in 29 of 66 treatments (44%), including citrate lock (19 of 66 treatments), responsive hypotension (8/66 high‐volume plasma exchange treatments), and transient hypothermia (3/66 HVPE treatments).
Conclusions
High‐volume plasma exchange is well tolerated in pediatric acute liver failure and can safely be used as a bridge to liver transplantation or spontaneous recovery. Adding heparin to a citrate anticoagulation strategy during high‐volume plasma exchange can decrease the frequency of citrate lock without increasing the risk of bleeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Critical Care, Nemours Children's Hospital, Delaware, Wilmington, Delaware, USA.
- Department of Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, University of Chicago Medicine, Chicago, Illinois, USA.
- Section of Pediatric Critical Care, Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.
- Biomedical Research, Nemours Children's Health, Delaware Valley, Wilmington, Delaware, USA.
ORCID-Profile: Amanda M Walker, Kevin D Smith, Joella L Slowik, Anna McCudden, Md J Hossain, Yosef Levenbrown
Zitieren
APA
Walker, A. M., Smith, K. D., Slowik, J. L., McCudden, A., Hossain, M. J., & Levenbrown, Y. (2025). A Novel Anticoagulation Strategy for High‐Volume Plasma Exchange in Pediatric Patients With Acute Liver Failure. Pediatric Transplantation. https://doi.org/10.1111/petr.70213
Vancouver
Walker AM, Smith KD, Slowik JL, McCudden A, Hossain MJ, Levenbrown Y. A Novel Anticoagulation Strategy for High‐Volume Plasma Exchange in Pediatric Patients With Acute Liver Failure. Pediatric Transplantation. 2025. doi:10.1111/petr.70213
BibTeX
@article{Walker2025,
author = {Walker, Amanda M and Smith, Kevin D and Slowik, Joella L and McCudden, Anna and Hossain, Md J and Levenbrown, Yosef},
title = {A Novel Anticoagulation Strategy for High‐Volume Plasma Exchange in Pediatric Patients With Acute Liver Failure},
journal = {Pediatric Transplantation},
year = {2025},
doi = {10.1111/petr.70213}
}
EUVIMED